Experienced in Panhypopituitarism

Dr. Roshanak Monzavi

Pediatric Endocrinology
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 
Experienced in Panhypopituitarism
Children's Hospital Los Angeles
4650 W Sunset Blvd, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Roshanak Monzavi is a Pediatric Endocrinologist in Los Angeles, California. Dr. Monzavi is rated as an Experienced provider by MediFind in the treatment of Panhypopituitarism. Her top areas of expertise are Type 1 Diabetes (T1D), Short Stature (Growth Disorders), Familial Short Stature (FSS), and Idiopathic Short Stature (ISS).

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Endocrinology
Licenses
Pediatric Endocrinology in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
View 5 Less Insurance Carriers -

Locations

Children's Hospital Los Angeles
4650 W Sunset Blvd, Los Angeles, CA 90027
Call: 323-361-4606

Additional Areas of Focus

Dr. Monzavi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
INHALE-1: A 26-week Primary Treatment Phase, With 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza® Versus Rapid-acting Insulin Analog Injections, Both in Combination With a Basal Insulin, in Pediatric Subjects With Type 1 or Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 06, 2025
Intervention Type: Biological
Study Drugs: Afrezza, Rapid-acting Insulin Analog, Basal Insulin
Study Phase: Phase 3
An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years
An Open-Label, Multi-Center, Single-Dose Study to Assess the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Nasal Glucagon in Pediatric Patients With Type 1 Diabetes Aged 1 to <4 Years
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Drug
Study Drug: Glucagon
Study Phase: Phase 1
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
The Effects of Vitamin D Supplementation on Glycemic Control and Proinflammatory Markers Involved in Microvascular Complications in Adolescents With Type 1 Diabetes.
Enrollment Status: Completed
Publish Date: May 08, 2017
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 5 Less Clinical Trials

16 Total Publications

INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
Journal: Diabetes care
Published: August 13, 2025
View All 16 Publications
Similar Doctors
Distinguished in Panhypopituitarism
Dr. Norman Lavin
Pediatric Endocrinology
Distinguished in Panhypopituitarism
Dr. Norman Lavin
Pediatric Endocrinology

Tarzana Pediatric Medical Group Inc.

18370 Burbank Blvd Ste 204, 
Tarzana, CA 
 (15.3 miles away)
818-345-7792
Languages Spoken:
English
See accepted insurances

Norman Lavin is a Pediatric Endocrinologist in Tarzana, California. Dr. Lavin is rated as a Distinguished provider by MediFind in the treatment of Panhypopituitarism. His top areas of expertise are Isolated Hypogonadotropic Hypogonadism, Hypopituitarism, Pediatric Growth Hormone Deficiency, and Sheehan Syndrome.

Distinguished in Panhypopituitarism
Dr. Amrit Bhangoo
Pediatric Endocrinology
Distinguished in Panhypopituitarism
Dr. Amrit Bhangoo
Pediatric Endocrinology
2650 Elm Ave, Ste # 210, 
Long Beach, CA 
 (21.0 miles away)
562-595-0166
Languages Spoken:
English
See accepted insurances

Amrit Bhangoo is a Pediatric Endocrinologist in Long Beach, California. Dr. Bhangoo is rated as a Distinguished provider by MediFind in the treatment of Panhypopituitarism. His top areas of expertise are Short Stature (Growth Disorders), Adrenal Insufficiency Pediatric, Panhypopituitarism, and Hypogonadism.

Advanced in Panhypopituitarism
Dr. Timothy Flannery
Pediatric Endocrinology
Advanced in Panhypopituitarism
Dr. Timothy Flannery
Pediatric Endocrinology
455 S Main St, 
Orange, CA 
 (32.7 miles away)
714-532-8634
Languages Spoken:
English
See accepted insurances

Timothy Flannery is a Pediatric Endocrinologist in Orange, California. Dr. Flannery is rated as an Advanced provider by MediFind in the treatment of Panhypopituitarism. His top areas of expertise are Pediatric Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Short Stature (Growth Disorders), and Sheehan Syndrome.

VIEW MORE PANHYPOPITUITARISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Monzavi's expertise for a condition
ConditionClose
      • Advanced
      • Familial Short Stature (FSS)
        Dr. Monzavi is
        Advanced
        . Learn about Familial Short Stature (FSS).
        See more Familial Short Stature (FSS) experts
      • Idiopathic Short Stature (ISS)
        Dr. Monzavi is
        Advanced
        . Learn about Idiopathic Short Stature (ISS).
        See more Idiopathic Short Stature (ISS) experts
      • Short Stature (Growth Disorders)
        Dr. Monzavi is
        Advanced
        . Learn about Short Stature (Growth Disorders).
        See more Short Stature (Growth Disorders) experts
      • Type 1 Diabetes (T1D)
        Dr. Monzavi is
        Advanced
        . Learn about Type 1 Diabetes (T1D).
        See more Type 1 Diabetes (T1D) experts
      • Experienced
      • Adrenal Insufficiency Pediatric
        Dr. Monzavi is
        Experienced
        . Learn about Adrenal Insufficiency Pediatric.
        See more Adrenal Insufficiency Pediatric experts
      • Cardiofaciocutaneous Syndrome
        Dr. Monzavi is
        Experienced
        . Learn about Cardiofaciocutaneous Syndrome.
        See more Cardiofaciocutaneous Syndrome experts
      • Cardiomyopathic Lentiginosis
        Dr. Monzavi is
        Experienced
        . Learn about Cardiomyopathic Lentiginosis.
        See more Cardiomyopathic Lentiginosis experts
      • Congenital Adrenal Hyperplasia (CAH)
        Dr. Monzavi is
        Experienced
        . Learn about Congenital Adrenal Hyperplasia (CAH).
        See more Congenital Adrenal Hyperplasia (CAH) experts
      • Congenital Hypothyroidism
        Dr. Monzavi is
        Experienced
        . Learn about Congenital Hypothyroidism.
        See more Congenital Hypothyroidism experts
      • Diabetic Ketoacidosis
        Dr. Monzavi is
        Experienced
        . Learn about Diabetic Ketoacidosis.
        See more Diabetic Ketoacidosis experts
      View All 23 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment